What is Doximity's AFS securities?

Doximity (DOCS) reported AFS securities of $0 in Q4 2025.

What is the long-term trend for Doximity's AFS securities?

Over 3 years (2021 to 2025), Doximity's AFS securities has grown at a -100.0% compound annual growth rate (CAGR), from $93.09M to $0.

What does AFS securities mean?

Debt securities classified as available-for-sale, measured at fair value with unrealized gains/losses in OCI rather than the income statement.

Doximity DOCS AFS Securities

AFS Securities at other companies

Veeva SystemsVEEV

——

Other financials

Income statement

See full

Revenue$145.4M+5.1%

Gross profit$126.0M+1.7%

Operating income$24.8M-49.0%

Net income$19.1M-69.4%

EPS (diluted)$0.10-67.7%

Balance sheet

See full

Cash & equivalents$219.2M+4.6%

Total debt$10.2M-17.8%

Total equity$950.8M-12.2%

Total assets$1.1B-11.1%

Cash flow

See full

Operating cash flow$109.5M+11.2%

CapEx-—

Free cash flow$81.6M-17.1%

Valuation

See full

Market cap$3.75B-60.5%

Profitability

See full

Gross margin89.1%-1.1pp

Operating margin33.3%-6.6pp

Net margin30.4%-8.7pp

FCF margin50.6%+2.7pp

Returns & leverage

See full

Return on equity19.3%-3.2pp

Debt / equity0×0.0×

Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest.

The official record: Doximity’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's afs securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Doximity's AFS securities?: Doximity (DOCS) reported AFS securities of $0 in Q4 2025.
What is the long-term trend for Doximity's AFS securities?: Over 3 years (2021 to 2025), Doximity's AFS securities has grown at a -100.0% compound annual growth rate (CAGR), from $93.09M to $0.
What does AFS securities mean?: Debt securities classified as available-for-sale, measured at fair value with unrealized gains/losses in OCI rather than the income statement.